We literally help you invest better.
We help self-directed investors and self-managed super funds (SMSF) make smarter investment decisions and get better returns.
We Cover
Fundamental
Analysis
Understand the companies vision, financials, assets, management and competitive advantages with Shares in Value.
Technical
Analysis
Execute your investing by using our technical indicators to make sure that you are investing at the right time to gain maximum upside.
Macro / Industry
Analysis
Find out how the global and economic factors can effect your investing and with our detailed industry analysis you can invest with precision.
Shares in Value Approach
Bored of hearing about the same stocks? With our unique and innovative approach discover the hidden gems on the ASX.
See Some Sample Reports
Is Brainchip a good investment in 2020 – 2021?
Afterpay Limited
Medibank Private Limited
Testimonail



Our Newsletter. Your Inbox
Get notified about company updates, news and blog posts. We hate spam.
Recent Post
Top 5 ASX-listed Dividend Stocks to Look Out For in 2021
Capital gains on investments comes with an added element of risk. Dividend income on the other hand is a lot safer comparatively. With ultra low interest rates likely to...
DigitalX Limited’s (ASX:DCC) Expansion Plan
DigitalX Limited (ASX: DCC) is a Perth headquartered FinTech company focused on blockchain consulting, digital asset funds management, and RegTech. DigitalX’s consulting division designs and develops blockchain technology applications...
Core Lithium (ASX:CXO) Acquires Six New MLs. Learn why.
Core Lithium (ASX: CXO) is an Adelaide based based mineral exploration company. Core Lithium engages in the acquisition, exploration, evaluation and development of copper, gold, uranium and iron ore...
Why did Australian Primary Hemp (ASX:APH) shares see a growth today?
Australian Primary Hemp Ltd. is a tiny biotechnology company, which engages in developing new human therapeutics based on its proprietary drug discovery, drug targeting and synthesis technologies. It involves...
Why did PYC Therapeutics (ASX:PYC) trade higher today?
PYC Therapeutics is an Australian drug-development company, which offers a new generation of RNA therapeutics to meet unmet needs in disease. It develops intracellular biological therapeutics including its own...